by Vora Corporate Finance | Feb 24, 2024 | Insights, Private Equity & IPO
PE: PlasmaGen Biosciences Raises $27 Million in Series C round. Transaction: Plasmagen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, has raised INR 225 crores, led by UK based Artian...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Economic Update: The IMF in annual Article IV consultation report acknowledged India’s effective inflation management amidst global commodity price hikes through extensive government interventions. It has projected a balanced outlook for India’s economic...
by Vora Corporate Finance | Jan 27, 2024 | Articles, Capital Market Updates
The Indian economy grew 7.6 per cent during the July – September quarter of the current financial year(Q2FY24), beating the earlier projections by RBI. The rise in GDP was supported by manufacturing, mining and construction sector. The stock markets also...
by Vora Corporate Finance | Jan 5, 2024 | Insights, Private Equity & IPO
Transaction: InCred Financial Services Ltd (InCred Finance), the lending arm of financial services firm InCred Group, has raised Rs. 500 Crore in its Series D round of funding, becoming the second startup to join the coveted ‘unicorn’ club this year. About Incred...
by Vora Corporate Finance | Jan 5, 2024 | Insights, Merger & Acquisitions
Transaction: Fortis Healthcare Ltd has announced that it has agreed to sell Fortis Malar Hospital (known as Malar Hospital) in Adyar, Chennai, and adjacent land parcels to MGM Healthcare Pvt. Ltd for a sale consideration of about Rs. 128 Crores. The transaction...
